Characteristics and Treatment Patterns of Patients With Sickle Cell Disease in Globin Research Network for Data and Discovery Registry

Completed

Conditions studied: Sickle Cell Disease

In brief

This was a retrospective observational cohort study. This study was a secondary analysis of individuals with sickle cell disease (SCD) enrolled in the GRNDaD registry.

Key facts

Study ID

NCT06662812

Run by

Novartis

People needed

1665

Starts

2021-10-06

Expected to finish

2023-12-01

Last updated by the study team

2024-10-29

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of SCD.
• Signed consent to participate in GRNDaD registry.

You may not qualify if…

• None identified at this time.

Where it is running

• Novartis Pharmaceuticals — East Hanover, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.